...
首页> 外文期刊>European heart journal cardiovascular Imaging >Atropine as an adjunct to supine bicycle stress echocardiography: An alternative strategy to achieve target heart rate or rate pressure product
【24h】

Atropine as an adjunct to supine bicycle stress echocardiography: An alternative strategy to achieve target heart rate or rate pressure product

机译:阿托品作为仰卧式自行车压力超声心动图的辅助手段:实现目标心率或心率压积的替代策略

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To investigate the use of atropine to achieve target heart rate (THR) and rate pressure product (RPP) during supine bicycle exercise stress echocardiography (SBESE) to increase the number of diagnostic stress tests. Methods and results: Forty-four patients that were unable to achieve THR or RPP during SBESE performed to evaluate ischaemia were given 0.4-1.2 mg of atropine to augment THR and RPP. After atropine (0.7±0.3 mg) the maximum heart rate (HR) achieved was 133 (±16) bpm, mean THR was 82% (±8%), and average RPP was 22 716 (±4915) b/min x mmHg. Of the patients with a non-diagnostic SBESE, with the use of atropine 80% of those patients achieved a diagnostic test. There were no major adverse affects from the administration of atropine. Conclusion: The use of atropine to augment the HR or RPP during SBESE (i) is safe; (ii) enables the assessment of ischaemia at peak effort; and (iii) allows assessment of exercise haemodynamics in patients with sub-maximal exercise capacity and chronotropic incompetence. Published on behalf of the European Society of Cardiology. All rights reserved.
机译:目的:研究在仰卧自行车运动压力超声心动图(SBESE)期间使用阿托品达到目标心率(THR)和速率压力乘积(RPP)的方法,以增加诊断性压力测试的次数。方法和结果:对44例在SBESE期间未能达到THR或RPP的患者进行缺血评估,并给予0.4-1.2mg阿托品以增加THR和RPP。使用阿托品(0.7±0.3 mg)后,最大心率(HR)为133(±16)bpm,平均THR为82%(±8%),平均RPP为22 716(±4915)b / min x mmHg 。在患有非诊断性SBESE的患者中,使用阿托品的患者中有80%达到了诊断测试。阿托品的给药没有重大不良影响。结论:在SBESE期间使用阿托品来增加HR或RPP是安全的; (ii)尽力评估缺血性; (iii)评估运动能力低于最大运动量和变时能力不足的患者的运动血流动力学。代表欧洲心脏病学会出版。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号